Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07712913 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Extended-release Pregabalin for the Treatment of Neuropathic Pain in Patients With Diabetic Peripheral Neuropathy and Postherpetic Neuralgia

Study acronym: PRISE
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Extended-release Pregabalin for the Treatment of Neuropathic Pain in Patients With Diabetic Peripheral Neuropathy and Postherpetic Neuralgia
Trial Details
NCT Number NCT07712913
Lead Sponsor Brainfarma Industria Química e Farmacêutica S/A
Conditions
(from sponsor)		 Diabetic Neuropathy, Neuropathic Pain, Neuralgia, Postherpetic
Related terms Diabetic Neuropathies, Neuralgia, Neuralgia, Postherpetic, Peripheral Nervous System Diseases
Enrollment 348 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov